(PGY1 and PGY2 Combined) Residency Investigational Drug Services and Research Pharmacy


Dr, Kim Redic, PharmD, BCPS
Residency Program Director

The Department of Pharmacy Services at the University of Michigan Hospitals and Health Centers is recruiting applicants for a two-year PGY1 Pharmacy & PGY2 on Investigational Drug Services and Research Pharmacy. This program is currently a candidate for ASHP accreditation.

Program Purpose

This two-year specialty residency training program in IDS/Research Pharmacy is designed to provide the resident with a wide array of experiences in clinical drug research while affording opportunities for collaboration with renowned clinicians and world-class experts in research, education, and population health. The program is designed to provide a strong clinical foundation while developing analytical, leadership, teaching, and writing skills. It will also provide experiences in clinical trial research and research pharmacy staffing experiences. The first year is aligned with the UMHS PGY1 program, with elective and longitudinal experiences in research-related areas. The PGY2 year provides specialized experiences in clinical research. Upon completion of the program, the resident will be prepared to secure a specialized pharmacist position in a variety of clinical research, regulatory, and drug development settings, including pharmaceutical industry, academia, and IDS practice.

PGY1 Year at a glance

  • Research Pharmacy Operations
  • Research Pharmacy Administration
  • Other rotations and requirements per the UMHS PGY1 program

Additional PGY1 longitudinal activities:

  • Longitudinal activities in a research-focused clinic
  • Staffing requirement in an area with a high volume of investigational drug dispensing
  • Teaching assignment at the College of Pharmacy related to research methodology
  • Teaching Certificate in cooperation with the College of Pharmacy

PGY2 Core Rotations:

  • Research Pharmacy Operations (2)
  • MICHR Clinical Trial Support Unit
  • IRB/Regulatory Affairs
  • Drug Development
  • Research Pharmacy Leadership (2)
  • MICHR - Investigator Assistance Program
  • McCreadie Group - Vestigo Team

PGY2 Elective Rotations:

  • FDA
  • Technology Transfer/Legal Affairs
  • Cancer Center Ravitz Phase I Unit
  • Drug Manufacturing
  • Ambulatory Research Clinic
  • Academia/Translational Medicine
  • Outcomes Research

PGY2 Longitudinal Experiences

  • Research project and writing project on a research-related topic
  • Longitudinal experience in a research-focused clinic
  • Staffing requirement in an area with a high volume of investigational drug dispensing


PGY1-Every other weekend alternating between direct patient care and distributive activities, and clinical on-call pager in one week increments.
PGY2- Every third weekend. 

Research and Publications

Through the research and writing requirements of the program, the resident has the potential to produce at least two manuscripts suitable for peer-reviewed publication by the end of the residency.

Program Assessment Strategy:

The program is structured in accordance with the ASHP Accreditation Standards and ASHP Educational Outcomes, Goals, and Objectives and utilizes the Residency Learning System model. This program has a four-part assessment strategy of learning experiences: resident evaluation of learning experience, resident evaluation of preceptor, resident self-evaluation, and preceptor evaluation of the resident's performance during the learning experience.

Residency Director Information:

Kim Redic, PharmD, BCPS
Program Director & Research Pharmacy Manager
Michigan Medicine, Department of Pharmacy Services

Clinical Assistant Professor 
University of Michigan College of Pharmacy
Phone: (734) 936-9699
Email: kredic@med.umich.edu

Residency Program Coordinator:

Pam Walker, PharmD, MHA, BCPS


Please check out the F.A.Q. for application deadlines and interview dates.